Treatment of four cases of intractable Meniere's disease with a new middle ear pressure device, Meniett®

Haruna Yabe, Fumiyuki Goto, Ken Hayashi, Takanobu Kunihiro, Kaoru Ogawa

Research output: Contribution to journalArticle

Abstract

It is not easy to treat patients with intractable Meniere's disease. Intratympanic injection of gentamicin or steroid is one option. The other is a surgical procedure like endolymphatic shunt surgery. Middle ear pressure treatment using the Meniett device, which has not been approved by the Japanese government is widely accepted in foreign countries. We had a chance to use this Meniett device under approval of the ethic's committee of Hino Municipal Hospital since September 2004. (Methods) Four patients with intractable Meniere's disease who suffered intensive vertigo attack for more than 5 months with conservative medical treatment were employed in the study. Ages ranged from 67 to 72, with 3 females and 1 male. After a ventilation tube was inserted under local anesthesia, treatment with the Meniett was performed 3 times a day at home. (Results) Two patients improved and 2 slightly improved concerning vertigo attacks. One showed no change, 1 experienced a worsening, and 2 showed slight improvement concerning the hearing level. (Conclusion) The Meniett device is less invasive and may be suitable for elderly patients who prefer conservative treatment. The mechanism involved in the reduction of vertigo attacks is not clear so far, but we speculate that middle ear pressure may suppress serum vasopressin (antidiuretic hormone) secretion and thereby reduce endolymphatic hydrops. It is necessary to accumulate treatment data with the Meniett in Japan to obtain official approval by the government.

Original languageEnglish
Pages (from-to)491-495
Number of pages5
JournalPractica Oto-Rhino-Laryngologica
Volume100
Issue number6
Publication statusPublished - 2007

Fingerprint

Meniere Disease
Middle Ear
Vertigo
Pressure
Equipment and Supplies
Vasopressins
Endolymphatic Shunt
Device Approval
Endolymphatic Hydrops
Municipal Hospitals
Ethics Committees
Local Anesthesia
Therapeutics
Gentamicins
Hearing
Ventilation
Japan
Steroids
Serum
Conservative Treatment

Keywords

  • Meniere's disease
  • Meniett
  • Middle ear pressure

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Treatment of four cases of intractable Meniere's disease with a new middle ear pressure device, Meniett®. / Yabe, Haruna; Goto, Fumiyuki; Hayashi, Ken; Kunihiro, Takanobu; Ogawa, Kaoru.

In: Practica Oto-Rhino-Laryngologica, Vol. 100, No. 6, 2007, p. 491-495.

Research output: Contribution to journalArticle

@article{750609d769d14a55af7e32b1cd6b98d4,
title = "Treatment of four cases of intractable Meniere's disease with a new middle ear pressure device, Meniett{\circledR}",
abstract = "It is not easy to treat patients with intractable Meniere's disease. Intratympanic injection of gentamicin or steroid is one option. The other is a surgical procedure like endolymphatic shunt surgery. Middle ear pressure treatment using the Meniett device, which has not been approved by the Japanese government is widely accepted in foreign countries. We had a chance to use this Meniett device under approval of the ethic's committee of Hino Municipal Hospital since September 2004. (Methods) Four patients with intractable Meniere's disease who suffered intensive vertigo attack for more than 5 months with conservative medical treatment were employed in the study. Ages ranged from 67 to 72, with 3 females and 1 male. After a ventilation tube was inserted under local anesthesia, treatment with the Meniett was performed 3 times a day at home. (Results) Two patients improved and 2 slightly improved concerning vertigo attacks. One showed no change, 1 experienced a worsening, and 2 showed slight improvement concerning the hearing level. (Conclusion) The Meniett device is less invasive and may be suitable for elderly patients who prefer conservative treatment. The mechanism involved in the reduction of vertigo attacks is not clear so far, but we speculate that middle ear pressure may suppress serum vasopressin (antidiuretic hormone) secretion and thereby reduce endolymphatic hydrops. It is necessary to accumulate treatment data with the Meniett in Japan to obtain official approval by the government.",
keywords = "Meniere's disease, Meniett, Middle ear pressure",
author = "Haruna Yabe and Fumiyuki Goto and Ken Hayashi and Takanobu Kunihiro and Kaoru Ogawa",
year = "2007",
language = "English",
volume = "100",
pages = "491--495",
journal = "Practica Oto-Rhino-Laryngologica",
issn = "0032-6313",
publisher = "Society of Practical Otolaryngology",
number = "6",

}

TY - JOUR

T1 - Treatment of four cases of intractable Meniere's disease with a new middle ear pressure device, Meniett®

AU - Yabe, Haruna

AU - Goto, Fumiyuki

AU - Hayashi, Ken

AU - Kunihiro, Takanobu

AU - Ogawa, Kaoru

PY - 2007

Y1 - 2007

N2 - It is not easy to treat patients with intractable Meniere's disease. Intratympanic injection of gentamicin or steroid is one option. The other is a surgical procedure like endolymphatic shunt surgery. Middle ear pressure treatment using the Meniett device, which has not been approved by the Japanese government is widely accepted in foreign countries. We had a chance to use this Meniett device under approval of the ethic's committee of Hino Municipal Hospital since September 2004. (Methods) Four patients with intractable Meniere's disease who suffered intensive vertigo attack for more than 5 months with conservative medical treatment were employed in the study. Ages ranged from 67 to 72, with 3 females and 1 male. After a ventilation tube was inserted under local anesthesia, treatment with the Meniett was performed 3 times a day at home. (Results) Two patients improved and 2 slightly improved concerning vertigo attacks. One showed no change, 1 experienced a worsening, and 2 showed slight improvement concerning the hearing level. (Conclusion) The Meniett device is less invasive and may be suitable for elderly patients who prefer conservative treatment. The mechanism involved in the reduction of vertigo attacks is not clear so far, but we speculate that middle ear pressure may suppress serum vasopressin (antidiuretic hormone) secretion and thereby reduce endolymphatic hydrops. It is necessary to accumulate treatment data with the Meniett in Japan to obtain official approval by the government.

AB - It is not easy to treat patients with intractable Meniere's disease. Intratympanic injection of gentamicin or steroid is one option. The other is a surgical procedure like endolymphatic shunt surgery. Middle ear pressure treatment using the Meniett device, which has not been approved by the Japanese government is widely accepted in foreign countries. We had a chance to use this Meniett device under approval of the ethic's committee of Hino Municipal Hospital since September 2004. (Methods) Four patients with intractable Meniere's disease who suffered intensive vertigo attack for more than 5 months with conservative medical treatment were employed in the study. Ages ranged from 67 to 72, with 3 females and 1 male. After a ventilation tube was inserted under local anesthesia, treatment with the Meniett was performed 3 times a day at home. (Results) Two patients improved and 2 slightly improved concerning vertigo attacks. One showed no change, 1 experienced a worsening, and 2 showed slight improvement concerning the hearing level. (Conclusion) The Meniett device is less invasive and may be suitable for elderly patients who prefer conservative treatment. The mechanism involved in the reduction of vertigo attacks is not clear so far, but we speculate that middle ear pressure may suppress serum vasopressin (antidiuretic hormone) secretion and thereby reduce endolymphatic hydrops. It is necessary to accumulate treatment data with the Meniett in Japan to obtain official approval by the government.

KW - Meniere's disease

KW - Meniett

KW - Middle ear pressure

UR - http://www.scopus.com/inward/record.url?scp=34347269238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347269238&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:34347269238

VL - 100

SP - 491

EP - 495

JO - Practica Oto-Rhino-Laryngologica

JF - Practica Oto-Rhino-Laryngologica

SN - 0032-6313

IS - 6

ER -